Related Experiment Video
Updated: Aug 6, 2026

03:23
Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Chronic Eosinophilic Leukemia Not Otherwise Specified: A Case Series
Neilmegh Lakshman Varada1, Katherine Dougherty Bordes2, Jordan P Redemann3
1Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Journal of Hematology
|July 23, 2026
Summary
Chronic eosinophilic leukemia, not otherwise specified (CEL-NOS) presents treatment challenges. This case series explores outcomes for two CEL-NOS patients, highlighting limited therapeutic options for this rare leukemia.
Area of Science:
- Hematology
- Oncology
- Rare Diseases
Background:
- Chronic eosinophilic leukemia (CEL) is a rare myeloproliferative neoplasm defined by elevated eosinophil counts.
- While some CEL cases have known mutations treatable with tyrosine kinase inhibitors (TKIs), many lack these mutations, termed CEL, not otherwise specified (CEL-NOS).
- Treatment guidance for CEL-NOS is limited, and the prognosis without targeted therapies is poor.